The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re:- Suspension

4 Mar 2020 09:15

RNS Number : 9823E
Asimilar Group PLC
04 March 2020
 

4 March 2020

 

 

Asimilar Group plc

("Asimilar" or the "Company")

 

Further re:- Suspension

 

 

Further to the announcement of 14 February 2020 in relation to the temporary suspension of the Company's shares from trading on AIM, the Company makes the following update.

 

The Company continues its discussions with Sentiance NV ("Sentiance"), a leading player in artificial intelligence ("AI"), machine learning and contextual behavioural data science, and intends to publish an admission document and to convene a General Meeting seeking shareholder approval for the readmission of the Company's shares to trading on AIM.

 

Subject to regulatory consents, the Company will seek shareholder approval to subscribe for 10,000 new Sentiance shares at a price of €750 per share for an aggregate consideration of €7,500,000 ("Initial Investment"). The Initial Investment would represent circa 9.3% of the enlarged share capital of Sentiance.

 

In addition, the Company would be granted an option to purchase 32,225 existing Sentiance shares at an exercise price of €650 per share ("Option 1") and a further option to subscribe for 10,000 new shares in Sentiance at an exercise price of €750 per share ("Option 2"). Shareholder consent would also be sought to enter into both Option 1 and Option 2.

 

Following the Initial Investment and assuming both Option 1 and Option 2 were exercised the Company would have an interest over circa 44.5% of Sentiance's so enlarged issued share capital, assuming no other Sentiance shares were issued, but is currently expected to have an aggregate interest of nearer 35.9% following the anticipated issue of further Sentiance shares to a third party and the exercise of share options by management and staff.

 

Due to the aggregate size of the proposed investment and the options relative to the Company's existing portfolio, the proposal will be classified as a reverse takeover under the AIM Rules and therefore will be conditional, inter alia, upon the approval of shareholders.

 

The Board confirms that the Company's shares will continue to be suspended pursuant to AIM Rule 40 pending the publication of an admission document with further details in relation to the proposed investments and fundraise, however, there is no guarantee that any definitive agreement will be reached with Sentiance.

Further announcements will be made in due course.

 

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

**ENDS**

Enquiries

Asimilar Group plc

John Taylor, Non-Executive Chairman

via Buchanan

Cairn Financial Advisers LLP

Sandy Jamieson, Liam Murray

Tel: +44 20 7213 0880

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Buchanan Communications Limited

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURKKQBDCBKKNNK
Date   Source Headline
18th Nov 20057:01 amRNSPositive Product Test Results
20th Oct 20057:00 amRNSTrading Statement
1st Aug 20059:27 amRNSBoard Appointment
29th Jul 20057:01 amRNSEgypt contract gain
8th Jul 200512:14 pmRNSResult of EGM
29th Jun 20055:30 pmRNSInterim Results
21st Jun 20057:00 amRNSOverseas Contract Gains
15th Jun 20054:03 pmRNSNotice of EGM
15th Jun 20052:21 pmRNSBoard Appointment
10th Jun 20057:00 amRNSOverseas Contract Gains
2nd Jun 20057:01 amRNSUS Collaboration deal
25th May 200512:30 pmRNSIssue of Equity
29th Mar 20051:13 pmRNSAGM Statement
2nd Feb 20054:51 pmRNSFinal Results Replacement
14th Jan 20051:39 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.